id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-P-1363-0006,FDA,FDA-2016-P-1363,"Letter to Gordon Johnston Regulatory Consultants, LLC",Other,Letter(s),2016-12-13T05:00:00Z,2016,12,2016-12-13T05:00:00Z,,2016-12-13T17:42:49Z,,0,0,090000648240195d
FDA-2016-P-1363-0005,FDA,FDA-2016-P-1363,"Determination That SODIUM CHLORIDE 23.4% IN PLASTIC CONTAINER 
(Sodium Chloride), Injectable, 234 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2016-12-12T05:00:00Z,2016,12,2016-12-12T05:00:00Z,,2016-12-12T14:18:25Z,2016-29674,0,0,09000064823f9857
FDA-2016-P-1363-0004,FDA,FDA-2016-P-1363,"Interim Response Letter from CDER to Gordon Johnston Regulatory Consultants, LLC",Other,Reply,2016-12-01T05:00:00Z,2016,12,2016-12-01T05:00:00Z,,2016-12-01T14:14:00Z,,0,0,09000064823a3c4c
FDA-2016-P-1363-0001,FDA,FDA-2016-P-1363,"Citizen Petition from Gordon Johnston Regulatory Consultants, LLC",Other,Citizen Petition,2016-05-27T04:00:00Z,2016,5,2016-05-27T04:00:00Z,,2016-05-27T10:41:57Z,,0,0,0900006481ff6f89
FDA-2016-P-1363-0003,FDA,FDA-2016-P-1363,"Attachment 1 Product Listing from the Discontinued Section of Orange Book re Gordon Johnston Regulatory Consultants, LLC",Supporting & Related Material,Background Material,2016-05-27T04:00:00Z,2016,5,,,2016-05-27T10:42:08Z,,0,0,0900006481ff7191
FDA-2016-P-1363-0002,FDA,FDA-2016-P-1363,"Acknowledgement Letter from FDA DDM to Gordon Johnston Regulatory Consultants, LLC",Other,Acknowledgement Letter/Receipt,2016-05-27T04:00:00Z,2016,5,2016-05-27T04:00:00Z,,2016-05-27T10:42:02Z,,0,0,0900006481ff6f8b